Breakthrough Treatment for Mantle Cell Lymphoma

Nahla A M Hamed
Additional contact information
Nahla A M Hamed: Alexandria University

Biomedical Journal of Scientific & Technical Research, 2017, vol. 1, issue 4, 865-868

Abstract: MCL has a dismal prognosis (“the worst lymphoma to have”), with a median OS rate of 3 years only. Prognosis of limited stage disease is almost similar to that of stage lll MCL No curative therapy has been established so far...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.000322.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.000322.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:1:y:2017:i:4:p:865-868

DOI: 10.26717/BJSTR.2017.01.000322

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().